Survodutide for Obesity in Chinese Adults: Phase 3 Randomized Trial Design and Baseline Characteristics (SYNCHRONIZE™-CN).

Ji L, Chen L, Cheng Z, Lu Y, Yang Y, Fu F, Zhu Y, Jin L, Kloer IM

Open source

DOI
10.1007/s13300-026-01908-x
Published
2026 Aug 14
Container
Diabetes therapy : research, treatment and education of diabetes and related disorders
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1007/s13300-026-01908-x,
  title = {Survodutide for Obesity in Chinese Adults: Phase 3 Randomized Trial Design and Baseline Characteristics (SYNCHRONIZE™-CN).},
  author = {Ji L and Chen L and Cheng Z and Lu Y and Yang Y and Fu F and Zhu Y and Jin L and Kloer IM},
  year = {2026},
  journal = {Diabetes therapy : research, treatment and education of diabetes and related disorders},
  doi = {10.1007/s13300-026-01908-x},
  url = {https://doi.org/10.1007/s13300-026-01908-x}
}

RIS

TY  - JOUR
TI  - Survodutide for Obesity in Chinese Adults: Phase 3 Randomized Trial Design and Baseline Characteristics (SYNCHRONIZE™-CN).
AU  - Ji L
AU  - Chen L
AU  - Cheng Z
AU  - Lu Y
AU  - Yang Y
AU  - Fu F
AU  - Zhu Y
AU  - Jin L
AU  - Kloer IM
PY  - 2026
JO  - Diabetes therapy : research, treatment and education of diabetes and related disorders
DO  - 10.1007/s13300-026-01908-x
UR  - https://doi.org/10.1007/s13300-026-01908-x
ER  - 

APA

L, J., L, C., Z, C., Y, L., Y, Y., F, F., Y, Z., L, J., & IM, K. (2026). Survodutide for Obesity in Chinese Adults: Phase 3 Randomized Trial Design and Baseline Characteristics (SYNCHRONIZE™-CN).. Diabetes therapy : research, treatment and education of diabetes and related disorders. https://doi.org/10.1007/s13300-026-01908-x

Source records